TCNNF / Trulieve Cannabis Corp. - Depositi SEC, Relazione annuale, dichiarazione di delega

Trulieve Cannabis Corp.
US ˙ OTCPK ˙ CA89788C1041

Statistiche di base
LEI 549300122MBOJDGEZ014
CIK 1754195
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Trulieve Cannabis Corp.
SEC Filings (Chronological Order)
Questa pagina fornisce un elenco completo e cronologico dei depositi SEC, esclusi i documenti di proprietà che forniamo altrove.
August 27, 2025 EX-99.2

EXECUTIVE EMPLOYMENT AGREEMENT

EXECUTIVE EMPLOYMENT AGREEMENT THIS EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”), effective as of September 8, 2025 (the “Effective Date”), is entered into by and between, Trulieve Cannabis Corp.

August 27, 2025 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 27, 2025 TRULIEVE CANNABIS

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 27, 2025 TRULIEVE CANNABIS CORP. (Exact Name of Registrant as specified in its charter) British Columbia 000-56248 84-2231905 (State or Other Jurisdiction of Incorporation) (Co

August 27, 2025 EX-99.1

Trulieve Announces Appointment of Board Member Matthew Foulston and Chief Financial Officer Jan Reese

Trulieve Announces Appointment of Board Member Matthew Foulston and Chief Financial Officer Jan Reese Tallahassee, Fla.

August 6, 2025 S-8

As filed with the Securities and Exchange Commission on August 6, 2025

S-8 As filed with the Securities and Exchange Commission on August 6, 2025 Registration No.

August 6, 2025 EX-FILING FEES

Filing Fee Table

Calculation of Filing Fee Tables S-8 Trulieve Cannabis Corp. Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee 1 Equity Subordinate Voting Shares, no par value Other 10,000,000 $ 4.69 $ 46,900,000.00 0.0001531 $ 7,180.39 Total Of

August 6, 2025 EX-99.2

Second Quarter 2025 Investor Presentation August 2025 CSE: TRUL OTCQX: TCNNF www.trulieve.com 2 Forward-Looking Statements Unless the context otherwise requires, the terms “Company,” “Trulieve,” “we,” “us” and “our” in this presentation refer to Trul

exhibit992tcnnfpresentat Second Quarter 2025 Investor Presentation August 2025 CSE: TRUL OTCQX: TCNNF www.

August 6, 2025 EX-99.1

Trulieve Reports Second Quarter 2025 Results Highlighting Progress on 2025 Plan •Second quarter revenue of $302 million, with 61% gross margin •Cash flow from operations of $137 million and free cash flow of $108 million* in the first half of 2025 •S

Exhibit 99.1 Trulieve Reports Second Quarter 2025 Results Highlighting Progress on 2025 Plan •Second quarter revenue of $302 million, with 61% gross margin •Cash flow from operations of $137 million and free cash flow of $108 million* in the first half of 2025 •Sold over 12.5 million branded products in the second quarter, up 9% compared to last year Tallahassee, FL – August 6, 2025 – Trulieve Can

August 6, 2025 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 o TRANSITION REPORT PU

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 00

August 6, 2025 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 6, 2025 TRULIEVE CANNABIS

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 6, 2025 TRULIEVE CANNABIS CORP. (Exact Name of Registrant as specified in its charter) British Columbia 000-56248 84-2231905 (State or Other Jurisdiction of Incorporation) (Com

June 30, 2025 EX-4.14

Form of Indenture

Exhibit 4.14 TRULIEVE CANNABIS CORP. as Issuer and [ ] as U.S. Trustee and [ ] as Canadian Trustee Indenture Dated as of [ ] TABLE OF CONTENTS Page RECITALS 1 ARTICLE ONE DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION 1.01 Definitions. 1 SECTION 1.02 Rules of Construction. 11 SECTION 1.03 Compliance Certificates and Opinions. 12 SECTION 1.04 Form of Documents Delivered to Truste

June 30, 2025 S-3ASR

As filed with the Securities and Exchange Commission on June 30, 2025

As filed with the Securities and Exchange Commission on June 30, 2025 Registration No.

June 30, 2025 EX-FILING FEES

Calculation of Filing Fee Table

Calculation of Filing Fee Tables S-3 Trulieve Cannabis Corp. Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Carry Forward Form Type Carry Forward File Number Carry Forward Initial Effective D

June 13, 2025 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 12, 2025 TRULIEVE CANNABIS C

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 12, 2025 TRULIEVE CANNABIS CORP. (Exact Name of Registrant as specified in its charter) British Columbia 000-56248 84-2231905 (State or Other Jurisdiction of Incorporation) (Comm

June 13, 2025 EX-10.1

Third Amended and Restated Trulieve Cannabis Corp. 2021 Omnibus Incentive Plan

Exhibit 10.1 APPENDIX B Third Amended and Restated Trulieve Cannabis Corp. 2021 Omnibus Incentive Plan (Amended and Restated April 24, 2025) Contents Article 1. Establishment, Purpose 1 Article 2. Definitions 2 Article 3. Administration 6 Article 4. Shares Subject to The Plan, Maximum Awards and Minimum Vesting Standards 8 Article 5. Eligibility and Participation 9 Article 6. Stock Options 10 Arti

May 7, 2025 EX-99.2

First Quarter 2025 Investor Presentation May 2025 CSE: TRUL OTCQX: TCNNF www.trulieve.com 2 Forward-Looking Statements Unless the context otherwise requires, the terms “Company,” “Trulieve,” “we,” “us” and “our” in this presentation refer to Trulieve

exhibit992tcnnfpresentat First Quarter 2025 Investor Presentation May 2025 CSE: TRUL OTCQX: TCNNF www.

May 7, 2025 EX-10.1

Executive Employment Agreement, dated February 26, 2025, by and between Trulieve Cannabis Corp. and Jason Pernell (incorporated by reference to Exhibit 10.17 of the Company’s Annual Report on Form 10-K filed with the SEC on February 27, 2025 (File No. 000-56248))

Exhibit 10.1 EXECUTIVE EMPLOYMENT AGREEMENT THIS EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”), effective as of February 26, 2025 (the “Effective Date”), is entered into by and between, Trulieve Cannabis Corp. (the “Company”), and Jason Pernell (the “Executive”). (The Company and the Executive are sometimes individually referred to herein as a “Party” and collectively as the “Parties”). WHEREA

May 7, 2025 EX-99.1

Trulieve Reports First Quarter 2025 Results Demonstrating Core Business Strength •First quarter revenue of $298 million, with 62% gross margin •Cash flow from operations of $51 million and free cash flow of $34 million* •4/20 holiday season units sol

Exhibit 99.1 Trulieve Reports First Quarter 2025 Results Demonstrating Core Business Strength •First quarter revenue of $298 million, with 62% gross margin •Cash flow from operations of $51 million and free cash flow of $34 million* •4/20 holiday season units sold and traffic increased 20% and 9%, respectively, year over year Tallahassee, FL – May 7, 2025 – Trulieve Cannabis Corp. (CSE: TRUL) (OTC

May 7, 2025 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 o TRANSITION REPORT P

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0

May 7, 2025 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 7, 2025 TRULIEVE CANNABIS COR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 7, 2025 TRULIEVE CANNABIS CORP. (Exact Name of Registrant as specified in its charter) British Columbia 000-56248 84-2231905 (State or Other Jurisdiction of Incorporation) (Commis

April 30, 2025 DEFR14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 1)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 1) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defi

April 29, 2025 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Defin

April 29, 2025 DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14

March 7, 2025 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 6, 2025 TRULIEVE CANNABIS C

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 6, 2025 TRULIEVE CANNABIS CORP. (Exact Name of Registrant as specified in its charter) British Columbia 000-56248 84-2231905 (State or Other Jurisdiction of Incorporation) (Comm

March 7, 2025 EX-99.1

Trulieve Announces Appointment of Ryan Blust as Interim Chief Financial Officer

Trulieve Announces Appointment of Ryan Blust as Interim Chief Financial Officer TALLAHASSEE, Fla.

February 27, 2025 EX-19.1

Insider Trading Policy

Exhibit 19.1 TRULIEVE CANNABIS CORP. INSIDER TRADING COMPLIANCE POLICY Adopted October 12, 2022 CONTENTS Page II. STATEMENT OF POLICIES PROHIBITING INSIDER TRADING 1 III. EXPLANATION OF INSIDER TRADING 2 IV. STATEMENT OF PROCEDURES PREVENTING INSIDER TRADING 6 V. ADDITIONAL PROHIBITED TRANSACTIONS 9 VI. RULE 10b5-1 TRADING PLANS, SECTION 16 AND RULE 144 11 VII. EXECUTION AND RETURN OF CERTIFICATIO

February 27, 2025 EX-21.1

Subsidiaries of the Registrant as of December 31, 2024

Exhibit 21.1 SUBSIDIARIES OF TRULIEVE CANNABIS CORP. Entity: Jurisdiction of Formation/Organization: 485 Bishop St, LLC Alabama Trulieve AL, Inc. Alabama 1633 S HWY 92, LLC Arizona 9275 W. Peoria Ave., LLC Arizona 938 Juanita, LLC Arizona Abedon Saiz, L.L.C. Arizona AD LLC Arizona Banyan Acquisition Corp. Arizona Banyan Cultivation Management, LLC Arizona Banyan Farms, LLC Arizona Banyan IP, LLC A

February 27, 2025 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-562

February 27, 2025 EX-99.2

Fourth Quarter / Full Year 2024 Investor Presentation February 2025 CSE: TRUL OTCQX: TCNNF www.trulieve.com 2 Forward-Looking Statements Unless the context otherwise requires, the terms “Company,” “Trulieve,” “we,” “us” and “our” in this presentation

Fourth Quarter / Full Year 2024 Investor Presentation February 2025 CSE: TRUL OTCQX: TCNNF www.

February 27, 2025 8-K

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 27, 2025 TRULIEVE CANNABIS CORP. (Exact Name of Registrant as specified in its charter) British Columbia 000-56248 84-2231905 (State or Other Jurisdiction of Incorporation) (

February 27, 2025 EX-99.1

Trulieve Reports Fourth Quarter and Full Year 2024 Results Highlighting Margins and Cash Flow •Fourth quarter revenue of $301 million, up 5% year over year, exceeding guidance •Gross margin of 62%, compared to 54% during the fourth quarter of 2023 •R

Exhibit 99.1 Trulieve Reports Fourth Quarter and Full Year 2024 Results Highlighting Margins and Cash Flow •Fourth quarter revenue of $301 million, up 5% year over year, exceeding guidance •Gross margin of 62%, compared to 54% during the fourth quarter of 2023 •Record 2024 cash flow from operations of $271 million and free cash flow of $150 million* Tallahassee, FL – February 27, 2025 – Trulieve C

February 27, 2025 EX-99.1

Appendix A (Licenses and Permits)

EXHIBIT 99.1 Appendix A Licenses and Permits State Entity Name Licensed Address License Type License # Regulators Expiration Date AZ Abedon Saiz, LLC (CHAA #8) 16635 N. Tatum Blvd, Phoenix, AZ 85032 State Retail License - Medical (includes Edible Authorization) 000000135DCSM00130984 Arizona Department of Health Services 01/21/27 AZ Abedon Saiz, LLC (CHAA #8) 16635 N. Tatum Blvd, Phoenix, AZ 85032

February 27, 2025 EX-10.17

ieve Cannabis Corp. and Jason Pernell

Exhibit 10.17 EXECUTIVE EMPLOYMENT AGREEMENT THIS EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”), effective as of February 26, 2025 (the “Effective Date”), is entered into by and between, Trulieve Cannabis Corp. (the “Company”), and Jason Pernell (the “Executive”). (The Company and the Executive are sometimes individually referred to herein as a “Party” and collectively as the “Parties”). WHERE

November 14, 2024 SC 13G/A

TCNNF / Trulieve Cannabis Corp. / NOMURA HOLDINGS INC Passive Investment

SC 13G/A 1 sayw2411141013ga.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Trulieve Cannabis Corp. (Name of Issuer) Subordinate Voting Shares, no par value (Title of Class of Securities) 89788C104 (CUSIP Number) September 30, 2024 (Date of Event which Requires Filing of this Statement) Check the

November 5, 2024 EX-99.1

Trulieve Reports Third Quarter 2024 Results Ahead of Florida Adult-Use Vote •Third quarter revenue of $284 million, up 3% year over year, in line with guidance •Gross margin of 61%, compared to 52% during the third quarter of 2023 •Year to date cash

Exhibit 99.1 Trulieve Reports Third Quarter 2024 Results Ahead of Florida Adult-Use Vote •Third quarter revenue of $284 million, up 3% year over year, in line with guidance •Gross margin of 61%, compared to 52% during the third quarter of 2023 •Year to date cash flow from operations of $241 million and free cash flow of $162 million* •Florida adult-use campaign support of $48 million during the th

November 5, 2024 8-K

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 5, 2024 TRULIEVE CANNABIS CORP. (Exact Name of Registrant as specified in its charter) British Columbia 000-56248 84-2231905 (State or Other Jurisdiction of Incorporation) (C

November 5, 2024 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 o TRANSITION REPO

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Numbe

November 5, 2024 EX-99.2

Third Quarter 2024 Investor Presentation November 2024 CSE: TRUL OTCQX: TCNNF www.trulieve.com 2 Forward Looking Statements and Industry Data Unless the context otherwise requires, the terms “Trulieve,” “we,” “us” and “our” in this presentation refer

Third Quarter 2024 Investor Presentation November 2024 CSE: TRUL OTCQX: TCNNF www.

September 18, 2024 SC 13G/A

CA:TRUL / Trulieve Cannabis Corp. / Rivers Kim A. - SC 13G/A Passive Investment

SC 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b),(c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. 3)1 Trulieve Cannabis Corp. (Name of Issuer) Subordinate Voting Shares, no par value (Title of Class of Securities) 89788c104 (CUSIP Number) Septembe

August 6, 2024 EX-10.4

Executive Employment Agreement, dated August 1, 2024, by and between Trulieve Cannabis Corp. and Kyle Landrum

Exhibit 10.4 EXECUTIVE EMPLOYMENT AGREEMENT THIS EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”), dated as of August 1, 2024 (the “Effective Date”), is entered into by and between, Trulieve Cannabis Corp. (the “Company”), and Kyle Landrum (the “Executive”). (The Company and the Executive are sometimes individually referred to herein as a “Party” and collectively as the “Parties”). WHEREAS, the C

August 6, 2024 EX-99.1

Trulieve Reports Second Quarter 2024 Results Exceeding Quarterly Guidance

Exhibit 99.1 Trulieve Reports Second Quarter 2024 Results Exceeding Quarterly Guidance •Second quarter performance of $303 million in revenue, up 2% sequentially and 8% year over year, and 60% gross margin •Launched Adult Use Sales in Ohio today at three locations •Major milestones include opening of 200th retail location and 8-year anniversary of first sale Tallahassee, FL – August 6, 2024 – Trul

August 6, 2024 EX-10.5

Executive Employment Agreement, dated August 1, 2024, by and between Trulieve Cannabis Corp. and Tim Morey

Exhibit 10.5 EXECUTIVE EMPLOYMENT AGREEMENT THIS EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”), dated as of August 1, 2024 (the “Effective Date”), is entered into by and between, Trulieve Cannabis Corp. (the “Company”), and Tim Morey (the “Executive”). (The Company and the Executive are sometimes individually referred to herein as a “Party” and collectively as the “Parties”). WHEREAS, the Comp

August 6, 2024 EX-10.2

Executive Employment Agreement, dated August 1, 2024, by and between Trulieve Cannabis Corp. and Kimberly Rivers

Exhibit 10.2 EXECUTIVE EMPLOYMENT AGREEMENT THIS EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”), dated as of August 1, 2024 (the “Effective Date”), is entered into by and between, Trulieve Cannabis Corp. (the “Company”), and Kimberly Rivers (the “Executive”). (The Company and the Executive are sometimes individually referred to herein as a “Party” and collectively as the “Parties”). WHEREAS, th

August 6, 2024 8-K

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 6, 2024 TRULIEVE CANNABIS CORP. (Exact Name of Registrant as specified in its charter) British Columbia 000-56248 84-2231905 (State or Other Jurisdiction of Incorporation) (Com

August 6, 2024 EX-10.3

Executive Employment Agreement, dated August 1, 2024, by and between Trulieve Cannabis Corp. and Eric Powers

Exhibit 10.3 EXECUTIVE EMPLOYMENT AGREEMENT THIS EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”), dated as of August 1, 2024 (the “Effective Date”), is entered into by and between, Trulieve Cannabis Corp. (the “Company”), and Eric Powers (the “Executive”). (The Company and the Executive are sometimes individually referred to herein as a “Party” and collectively as the “Parties”). WHEREAS, the Co

August 6, 2024 EX-99.2

Second Quarter 2024 Investor Presentation August 2024 CSE: TRUL OTCQX: TCNNF www.trulieve.com 2 Forward Looking Statements and Industry Data Unless the context otherwise requires, the terms “Trulieve,” “we,” “us” and “our” in this presentation refer

Second Quarter 2024 Investor Presentation August 2024 CSE: TRUL OTCQX: TCNNF www.trulieve.com 2 Forward Looking Statements and Industry Data Unless the context otherwise requires, the terms “Trulieve,” “we,” “us” and “our” in this presentation refer to Trulieve Cannabis Corp. and its subsidiaries. Certain statements in this presentation constitute forward-looking statements within the meaning of t

August 6, 2024 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 o TRANSITION REPORT PU

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 00

June 21, 2024 S-8

As filed with the Securities and Exchange Commission on June 21, 2024

As filed with the Securities and Exchange Commission on June 21, 2024 Registration No.

June 21, 2024 EX-FILING FEES

Filing Fee Table

EX-FILING FEES EXHIBIT 107 CALCULATION OF FILING FEE TABLE Form S-8 (Form Type) TRULIEVE CANNABIS CORP.

June 13, 2024 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 12, 2024 TRULIEVE CANNABIS C

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 12, 2024 TRULIEVE CANNABIS CORP. (Exact Name of Registrant as specified in its charter) British Columbia 000-56248 84-2231905 (State or Other Jurisdiction of Incorporation) (Comm

June 13, 2024 EX-10.1

Second Amended and Restated Trulieve Cannabis Corp. 2021 Omnibus Incentive Plan (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on June 13, 2024 (File No. 000-56248))

Exhibit 10.1 Second Amended and Restated Trulieve Cannabis Corp. 2021 Omnibus Incentive Plan (Amended and Restated April 24, 2024) Contents Article 1. Establishment, Purpose 1 Article 2. Definitions 2 Article 3. Administration 6 Article 4. Shares Subject to The Plan, Maximum Awards and Minimum Vesting Standards 7 Article 5. Eligibility and Participation 8 Article 6. Stock Options 9 Article 7. Stoc

May 9, 2024 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 9, 2024 TRULIEVE CANNABIS COR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 9, 2024 TRULIEVE CANNABIS CORP. (Exact Name of Registrant as specified in its charter) British Columbia 000-56248 84-2231905 (State or Other Jurisdiction of Incorporation) (Commis

May 9, 2024 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 o TRANSITION REPORT PUR

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-56248 TRULIEVE CANNABIS CORP.

May 9, 2024 EX-99.1

Exhibit 99.1 Trulieve Reports First Quarter 2024 Results Demonstrating Core Business Strength and Cash Generation • First quarter performance of $298 million in revenue, up 4% sequentially, and 58% gross margin • Strong cash flow from operations of $

tcnnf-2024xq1xexx991 Exhibit 99.1 Trulieve Reports First Quarter 2024 Results Demonstrating Core Business Strength and Cash Generation • First quarter performance of $298 million in revenue, up 4% sequentially, and 58% gross margin • Strong cash flow from operations of $139 million and free cash flow of $124 million* in Q1 2024 • Definitive progress made on Smart and Safe Florida adult use initiat

May 9, 2024 EX-99.2

First Quarter 2024 Investor Presentation May 2024 CSE: TRUL OTCQX: TCNNF www.trulieve.com 2 Forward Looking Statements and Industry Data Unless the context otherwise requires, the terms “Trulieve,” “we,” “us” and “our” in this presentation refer to T

trulieveq12024earningspr First Quarter 2024 Investor Presentation May 2024 CSE: TRUL OTCQX: TCNNF www.

April 30, 2024 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Defin

April 29, 2024 DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14

April 23, 2024 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): April 17, 2024 TRULIEVE CANNABIS CORP. (Exact Name of Registrant as specified in its charter) British Columbia 000-56248 84-2231905 (State or Other Jurisdiction of Incorporation) (Com

March 29, 2024 8-K

Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 25, 2024 TRULIEVE CANNABIS CORP. (Exact Name of Registrant as specified in its charter) British Columbia 000-56248 84-2231905 (State or Other Jurisdiction of Incorporation) (Com

March 29, 2024 EX-16.1

Letter from Marcum LLP to the Securities and Exchange Commission dated March 29, 2024

Marcum llp / 525 Okeechobee Boulevard / Suite 750 / West Palm Beach, FL 33401 / Phone 561.

February 29, 2024 EX-99.1

Exhibit 99.1 Trulieve Reports Fourth Quarter and Full Year 2023 Results Highlighting Year End Momentum and Cash Generation • Fourth quarter performance delivered highest revenue and gross margin for the year • Record cash flow from operations of $202

Exhibit 99.1 Trulieve Reports Fourth Quarter and Full Year 2023 Results Highlighting Year End Momentum and Cash Generation • Fourth quarter performance delivered highest revenue and gross margin for the year • Record cash flow from operations of $202 million and free cash flow of $161 million* in 2023 • Expect 2024 cash flow from operations of at least $225 million Tallahassee, FL – February 29, 2

February 29, 2024 EX-10.21

Executive Employment Agreement, dated January 1, 2024, by and between Trulieve Cannabis Corp. and Wes Getman (incorporated by reference to Exhibit 10.21 of the Company's Annual Report on Form 10-K filed with the SEC on February 29, 2024 (File No. 000-56248)).

Exhibit 10.21 EXECUTIVE EMPLOYMENT AGREEMENT THIS EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”), effective as of January 1, 2024 (the “Effective Date”), is entered into by and between, Trulieve Cannabis Corp. (the “Company”), and Wes Getman (the “Executive”). (The Company and the Executive are sometimes individually referred to herein as a “Party” and collectively as the “Parties”). WHEREAS, t

February 29, 2024 8-K

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 29, 2024 TRULIEVE CANNABIS CORP. (Exact Name of Registrant as specified in its charter) British Columbia 000-56248 84-2231905 (State or Other Jurisdiction of Incorporation) (

February 29, 2024 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 000-562

February 29, 2024 EX-99.2

Fourth Quarter and Full Year 2023 Investor Presentation February 2024 CSE: TRUL OTCQX: TCNNF www.trulieve.com 2 Forward Looking Statements and Industry Data Unless the context otherwise requires, the terms “Trulieve,” “we,” “us” and “our” in this pre

Fourth Quarter and Full Year 2023 Investor Presentation February 2024 CSE: TRUL OTCQX: TCNNF www.

February 29, 2024 EX-10.32

Loan Agreement dated December 22, 2023 between Trulieve Centaury Way, LLC and First Federal Bank

Exhibit 10.32 LOAN AGREEMENT by and between TRULIEVE CENTAURY WAY, LLC, as Borrower and FIRST FEDERAL BANK, as Lender Dated: as of December , 2023 Active\1606212456.7 LOAN AGREEMENT THIS LOAN AGREEMENT (“Agreement”) dated this day of December 2023 and made effective as of December 22, 2023, by and between TRULIEVE CENTAURY WAY, LLC, a Florida limited liability company (“Borrower”), having a mailin

February 29, 2024 EX-21.1

Subsidiaries of the Registrant as of December 31, 2023

Exhibit 21.1 SUBSIDIARIES OF TRULIEVE CANNABIS CORP. Entity: Jurisdiction of Formation/Organization: Trulieve AL, Inc. Alabama 1633 S HWY 92, LLC Arizona 9275 W. Peoria Ave., LLC Arizona 938 Juanita, LLC Arizona Abedon Saiz, L.L.C. Arizona AD LLC Arizona AZ Sea Holdings, LLC Arizona Banyan Acquisition Corp. Arizona Banyan Cultivation Management, LLC Arizona Banyan Farms, LLC Arizona Banyan IP, LLC

February 29, 2024 EX-10.22

Executive Employment Agreement, dated January 29, 2024, by and between Trulieve Cannabis Corp. and Marie Zhang (incorporated by reference to Exhibit 10.22 of the Company's Annual Report on Form 10-K filed with the SEC on February 29, 2024 (File No. 000-56248)).

Exhibit 10.22 EXECUTIVE EMPLOYMENT AGREEMENT THIS EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”), effective as of January 29, 2024 (the “Effective Date”), is entered into by and between, Trulieve Cannabis Corp. (the “Company”), and Marie Zhang (the “Executive”). (The Company and the Executive are sometimes individually referred to herein as a “Party” and collectively as the “Parties”). WHEREAS,

February 29, 2024 EX-99.1

Appendix A (Licenses and Permits)

EXHIBIT 99.1 Appendix A Licenses and Permits State Entity Name Licensed Address Type License # Expiration Date Regulator AZ Abedon Saiz, LLC (CHAA #8) 16635 N. Tatum Blvd, Phoenix, AZ 85032 State Retail License - Medical (includes Edible Authorization) 000000135DCSM00130984 01/21/25 Arizona Department of Health Services AZ Abedon Saiz, LLC (CHAA #8) 16635 N. Tatum Blvd, Phoenix, AZ 85032 State Ret

February 14, 2024 SC 13G/A

CA:TRUL / Trulieve Cannabis Corp. / Rivers Kim A. - SC 13G/A Passive Investment

SC 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b),(c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. 2)1 Trulieve Cannabis Corp. (Name of Issuer) Subordinate Voting Shares, no par value (Title of Class of Securities) 89788c104 (CUSIP Number) December

February 14, 2024 SC 13G

TCNNF / Trulieve Cannabis Corp. / NOMURA HOLDINGS INC Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Trulieve Cannabis Corp. (Name of Issuer) Subordinate Voting Shares, no par value (Title of Class of Securities) 89788C104 (CUSIP Number) December 31, 2023 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the r

February 14, 2024 SC 13G/A

CA:TRUL / Trulieve Cannabis Corp. / Beshears Thad - SC 13G/A Passive Investment

SC 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b),(c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. 2 – Exit Filing) 1 Trulieve Cannabis Corp. (Name of Issuer) Subordinate Voting Shares, no par value (Title of Class of Securities) 89788c104 (CUSIP N

February 2, 2024 SC 13G/A

CA:TRUL / Trulieve Cannabis Corp. / Cowen Financial Products LLC - COWEN FINANCIAL PRODUCTS LLC Passive Investment

SC 13G/A 1 tcnnfa320224.htm COWEN FINANCIAL PRODUCTS LLC UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* Trulieve Cannabis Corp. (Name of Issuer) Common Stock (Title of Class of Securities) 89788c104 (CUSIP Number) December 29, 2023 (Date of Event which Requires Filing of this Statement) Check the app

January 18, 2024 EX-99.1

Trulieve Announces Appointment of Marie Zhang as Chief Operating Officer

Trulieve Announces Appointment of Marie Zhang as Chief Operating Officer Tallahassee, Fla.

January 18, 2024 8-K

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 17, 2024 (January 12, 2024) TRULIEVE CANNABIS CORP. (Exact Name of Registrant as specified in its charter) British Columbia 000-56248 84-2231905 (State or Other Jurisdiction o

December 22, 2023 EX-99.1

Trulieve Announces Appointment of Wes Getman as Chief Financial Officer

Trulieve Announces Appointment of Wes Getman as Chief Financial Officer Tallahassee, Fla.

December 22, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 22, 2023 TRULIEVE CANNAB

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 22, 2023 TRULIEVE CANNABIS CORP. (Exact Name of Registrant as specified in its charter) British Columbia 000-56248 84-2231905 (State or Other Jurisdiction of Incorporation) (

December 1, 2023 EX-99.1

Trulieve Announces Completion of Redemption of All US$130 Million 9.75% Senior Secured Notes due 2024

Exhibit 99.1 Trulieve Announces Completion of Redemption of All US$130 Million 9.75% Senior Secured Notes due 2024 Tallahassee, Fla. – December 1, 2023 – Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company in the U.S., today announced that it has completed the redemption of all US$130,000,000 (Cdn$175,669,000) principal am

December 1, 2023 8-K

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 1, 2023 TRULIEVE CANNABIS CORP. (Exact Name of Registrant as specified in its charter) British Columbia 000-56248 84-2231905 (State or Other Jurisdiction of Incorporation) (C

November 9, 2023 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 o TRANSITION REPORT

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-56248 TRULIEVE CANNABIS CORP.

November 9, 2023 EX-99.2

Third Quarter 2023 Investor Presentation / November 2023 CSE: TRUL OTCQX: TCNNF Exhibit 99.2 www.trulieve.com 2 Forward Looking Statements and Industry Data Unless the context otherwise requires, the terms “Trulieve,” “we,” “us” and “our” in this pre

Third Quarter 2023 Investor Presentation / November 2023 CSE: TRUL OTCQX: TCNNF Exhibit 99.

November 9, 2023 EX-99.1

Trulieve Reports Third Quarter 2023 Results Delivering Significant Cash Generation • Generated cash flow from operations of $93 million and free cash flow of $87 million • Reduced debt with purchase of $57 million of 2026 notes and announced redempti

Trulieve Reports Third Quarter 2023 Results Delivering Significant Cash Generation • Generated cash flow from operations of $93 million and free cash flow of $87 million • Reduced debt with purchase of $57 million of 2026 notes and announced redemption of $130 million of 2024 notes, resulting in $20 million in interest savings through maturity • Expect 2023 operating cash flow of at least $100 million and free cash flow of at least $70 million Tallahassee, FL – November 9, 2023 – Trulieve Cannabis Corp.

November 9, 2023 8-K

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 9, 2023 TRULIEVE CANNABIS CORP. (Exact Name of Registrant as specified in its charter) British Columbia 000-56248 84-2231905 (State or Other Jurisdiction of Incorporation) (C

November 8, 2023 8-K

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 8, 2023 TRULIEVE CANNABIS CORP. (Exact Name of Registrant as specified in its charter) British Columbia 000-56248 84-2231905 (State or Other Jurisdiction of Incorporation) (C

November 8, 2023 EX-99.1

Trulieve Announces Notice of Redemption for All US$130 Million of its 9.75% Senior Secured Notes due 2024

EX-99.1 Exhibit 99.1 Trulieve Announces Notice of Redemption for All US$130 Million of its 9.75% Senior Secured Notes due 2024 Tallahassee, Fla. – November 8, 2023 – Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company in the U.S., today announced it has issued a notice of redemption for all of its outstanding 9.75% senior

October 13, 2023 EX-99.1

Trulieve Announces Filing of Amended Federal Tax Returns Claiming $143 Million Refund

Exhibit 99.1 Trulieve Announces Filing of Amended Federal Tax Returns Claiming $143 Million Refund Tallahassee, Fla. – October 13, 2023 – Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company in the United States, today announced the filing of amended federal tax returns with refund claims for several of the Company’s busine

October 13, 2023 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 13, 2023 TRULIEVE CANNABIS CORP. (Exact Name of Registrant as specified in its charter) British Columbia 000-56248 84-2231905 (State or Other Jurisdiction of Incorporation) (C

September 21, 2023 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): September 21, 2023 TRULIEVE CANNABIS CORP. (Exact Name of Registrant as specified in its charter) British Columbia 000-56248 84-2231905 (State or Other Jurisdiction of Incorporation)

September 21, 2023 EX-99.1

Trulieve Announces Purchase of 8% Senior Secured Notes due 2026

Exhibit 99.1 Trulieve Announces Purchase of 8% Senior Secured Notes due 2026 Tallahassee, Fla. – September 21, 2023 – Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company in the U.S., today announced the open market purchase of 57,000 of its USD $1,000 face value senior secured notes due October 6, 2026 (the “Notes”) for a

August 9, 2023 EX-99.2

Forward Looking Statements and Industry Data Unless the context otherwise requires, the terms “Trulieve,” “we,” “us” and “our” in this presentation refer to Trulieve Cannabis Corp. and its subsidiaries. Certain statements in this presentation constit

Second Quarter 2023 Investor Presentation / August 2023 CSE: TRUL OTCQX: TCNNF Exhibit 99.

August 9, 2023 EX-10.5

Form of Restricted Stock Unit Award Agreement for Executive Officers

Exhibit 10.5 AMENDED AND RESTATED Trulieve Cannabis Corp. 2021 OMNIBUS Incentive Plan RESTRICTED STOCK UNIT AWARD AGREEMENT Trulieve Cannabis Corp. (the “Company”) hereby grants to the Participant named below Restricted Stock Units (“Restricted Stock Units” or “RSUs”) pursuant to the Trulieve Cannabis Corp. 2021 Omnibus Incentive Plan, as amended thereafter (the “Plan”), in the number specified be

August 9, 2023 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-56248 TRULIEVE CANNABIS CORP.

August 9, 2023 EX-10.6

Form of Nonqualified Stock Option Agreement for Directors

Exhibit 10.6 Amended and Restatd Trulieve Cannabis Corp. 2021 OMNIBUS Incentive Plan NONQUALIFIED STOCK OPTION AWARD AGREEMENT Trulieve Cannabis Corp. (the “Company”) hereby grants to the Participant named below nonqualified stock option (the “Option”) pursuant to the Trulieve Cannabis Corp. 2021 Omnibus Incentive Plan, as amended thereafter, (the “Plan”) to purchase any part or all of the number

August 9, 2023 EX-10.7

Form of Nonqualified Stock Option Agreement for Executive Officers

Exhibit 10.7 AMENDED AND RESTATED Trulieve Cannabis Corp. 2021 OMNIBUS Incentive Plan RESTRICTED STOCK UNIT AWARD AGREEMENT Trulieve Cannabis Corp. (the “Company”) hereby grants to the Participant named below Restricted Stock Units (“Restricted Stock Units” or “RSUs”) pursuant to the Trulieve Cannabis Corp. 2021 Omnibus Incentive Plan, as amended thereafter (the “Plan”), in the number specified be

August 9, 2023 EX-99.1

Trulieve Reports Second Quarter 2023 Results Highlighting Progress on 2023 Plan

EX-99.1 Exhibit 99.1 Trulieve Reports Second Quarter 2023 Results Highlighting Progress on 2023 Plan • Sold 11.6 million units of branded product through branded retail, up 9% sequentially • Maryland dispensary traffic increased 200% in July with adult use launch • Industry leading U.S. retail network of 183 dispensaries, up 11% year over year, supported by over 4 million square feet of cultivatio

August 9, 2023 EX-10.3

Executive Employment Agreement, dated September 29, 2021, by and between Trulieve Cannabis Corp. and

Exhibit 10.3 EXECUTIVE EMPLOYMENT AGREEMENT THIS EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”), dated as of September 29, 2021 (the “Effective Date”), is entered into by and between, Trulieve Cannabis Corp. (the “Company”), and Ryan Blust (the “Executive”). (The Company and the Executive are sometimes individually referred to herein as a “Party” and collectively as the “Parties”). WHEREAS, the

August 9, 2023 8-K

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 9, 2023 TRULIEVE CANNABIS CORP. (Exact Name of Registrant as specified in its charter) British Columbia 000-56248 84-2231905 (State or Other Jurisdiction of Incorporation) (Com

August 9, 2023 EX-10.2

Executive Employment Agreement, dated June 18, 2023, by and between Trulieve Cannabis Corp. and Timothy Mullany.

Exhibit 10.2 EXECUTIVE EMPLOYMENT AGREEMENT THIS EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”), effective as of July 1, 2023 (the “Effective Date”), is entered into by and between, Trulieve Cannabis Corp. (the “Company”), and Timothy Mullany (the “Executive”). (The Company and the Executive are sometimes individually referred to herein as a “Party” and collectively as the “Parties”). WHEREAS,

August 9, 2023 EX-10.4

Form of Restricted Stock Unit Award Agreement for Directors (Immediate or Deferred Settlement)

Exhibit 10.4 AMENDED AND RESTATED Trulieve Cannabis Corp. 2021 OMNIBUS Incentive Plan RESTRICTED STOCK UNIT AWARD AGREEMENT [(Immediate Settlement)]1 / [(Deferred Settlement)]2 Trulieve Cannabis Corp. (the “Company”) hereby grants to the Participant named below Restricted Stock Units (“Restricted Stock Units” or “RSUs”), pursuant to the Amended and Restated Trulieve Cannabis Corp. 2021 Omnibus Inc

July 21, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): July 20, 2023 TRULIEVE CANNABIS C

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): July 20, 2023 TRULIEVE CANNABIS CORP. (Exact Name of Registrant as specified in its charter) British Columbia 000-56248 84-2231905 (State or Other Jurisdiction of Incorporation) (Comm

July 21, 2023 EX-99.1

Trulieve Announces Appointment of Ryan Blust as Interim Chief Financial Officer

EX-99.1 Exhibit 99.1 Trulieve Announces Appointment of Ryan Blust as Interim Chief Financial Officer TALLAHASSEE, Fla. – July 21, 2023 – Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company in the United States, today announced the appointment of Ryan Blust, the Company’s Vice President, Finance, as its interim Chief Financ

June 28, 2023 EX-FILING FEES

Filing Fee Table

EX-FILING FEES EXHIBIT 107 CALCULATION OF FILING FEE TABLE Form S-8 (Form Type) TRULIEVE CANNABIS CORP.

June 28, 2023 S-8

Power of attorney (included on signature page of this Registration Statement).

S-8 As filed with the Securities and Exchange Commission on June 27, 2023 Registration No.

June 20, 2023 EX-10.1

Amended and Restated Trulieve Cannabis Corp. 2021 Omnibus Incentive Plan (incorporated by references to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K (File No. 000-56248)).

EX-10.1 Exhibit 10.1 Amended and Restated Trulieve Cannabis Corp. 2021 Omnibus Incentive Plan (Amended and Restated April 26, 2023) Contents Article 1. Establishment, Purpose 1 Article 2. Definitions 2 Article 3. Administration 6 Article 4. Shares Subject to The Plan, Maximum Awards and Minimum Vesting Standards 8 Article 5. Eligibility and Participation 9 Article 6. Stock Options 10 Article 7. St

June 20, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 20, 2023 (June 14, 2023) TRU

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 20, 2023 (June 14, 2023) TRULIEVE CANNABIS CORP. (Exact Name of Registrant as specified in its charter) British Columbia 000-56248 84-2231905 (State or Other Jurisdiction of Inco

June 20, 2023 EX-99.1

Trulieve Announces Appointment of Tim Mullany as Chief Financial Officer

EX-99.1 Exhibit 99.1 Trulieve Announces Appointment of Tim Mullany as Chief Financial Officer TALLAHASSEE, Fla. – June 19, 2023 – Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company in the United States, today announced the appointment of Tim Mullany as Chief Financial Officer, effective July 10, 2023. Mr. Mullany has over

June 20, 2023 8-K

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 20, 2023 (June 18, 2023) TRULIEVE CANNABIS CORP. (Exact Name of Registrant as specified in its charter) British Columbia 000-56248 84-2231905 (State or Other Jurisdiction of Inco

May 10, 2023 EX-10

First Amendment to Loan Agreement, dated as of May 9, 2023 and effective as of December 21, 2022

Exhibit 10.2 FIRST AMENDMENT TO LOAN AGREEMENT VALLEY NATIONAL BANK, AS AGENT AND THE LENDERS NAMED HEREIN, AS LENDERS, AND TRULIEVE CAPPS HIGHWAY LLC (the "Borrower") Certain identified information has been excluded from this exhibit because it is not material and is the type of information that the Registrant customarily and actually treats as private and confidential. Redacted information is in

May 10, 2023 10-Q

Form 10-Q

i UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-56248 TRULIEVE CANNABIS CORP.

May 10, 2023 EX-99.2

Forward Looking Statements and Industry Data Unless the context otherwise requires, the terms “Trulieve,” “we,” “us” and “our” in this presentation refer to Trulieve Cannabis Corp. and its subsidiaries. Certain statements in this presentation constit

EX-99.2 First Quarter 2023 Investor Presentation / May 2023 CSE: TRUL OTCQX: TCNNF Exhibit 99.2 Forward Looking Statements and Industry Data Unless the context otherwise requires, the terms “Trulieve,” “we,” “us” and “our” in this presentation refer to Trulieve Cannabis Corp. and its subsidiaries. Certain statements in this presentation constitute forward-looking statements within the meaning of t

May 10, 2023 EX-10

Executive Employment Agreement, dated January 3, 2023, by and between Trulieve Cannabis Corp. and Joy Malivuk

EX-10 2 tcnnf-ex101.htm EX-10.1 Exhibit 10.1 EXECUTIVE EMPLOYMENT AGREEMENT THIS EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”), dated as of January 3, 2023 (the “Effective Date”), is entered into by and between, Trulieve Cannabis Corp. (the “Company”), and Joy Malivuk (the “Executive”). (The Company and the Executive are sometimes individually referred to herein as a “Party” and collectively a

May 10, 2023 EX-99.1

Trulieve Reports First Quarter 2023 Results Marking Progress on Cash Objectives

EX-99.1 Exhibit 99.1 Trulieve Reports First Quarter 2023 Results Marking Progress on Cash Objectives • Record 4/20 results with traffic, customers served, and units sold up 10%, 11%, and 9%, respectively, year over year • Cost reduction initiatives deliver $24 million decrease in SG&A expenses • Industry leading U.S. retail network of 184 dispensaries, up 14% year over year, supported by over 4 mi

May 10, 2023 8-K

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 10, 2023 TRULIEVE CANNABIS CORP. (Exact Name of Registrant as specified in its charter) British Columbia 000-56248 84-2231905 (State or Other Jurisdiction of Incorporation) (Commi

May 10, 2023 EX-10

on the Company's Quarterly Report on Form 10-Q for the period ended March 31, 2023, as filed with the SEC on May 10, 2023 (File No. 000-56248)).

Exhibit 10.3 SECOND AMENDMENT TO LOAN AGREEMENT VALLEY NATIONAL BANK, AS AGENT AND THE LENDERS NAMED HEREIN, AS LENDERS, AND TRULIEVE CAPPS HIGHWAY LLC (the "Borrower") SECOND AMENDMENT TO LOAN AGREEMENT This Second Amendment (“Amendment”) to Loan Agreement dated as of the 9th day of May, 2023 between TRULIEVE CAPPS HIGHWAY LLC, a Florida limited liability company (“Borrower”), having a mailing ad

May 1, 2023 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

May 1, 2023 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): April 26, 2023 TRULIEVE CANNABIS CORP. (Exact Name of Registrant as specified in its charter) British Columbia 000-56248 84-2231905 (State or Other Jurisdiction of Incorporation) (Com

May 1, 2023 DEF 14A

proxy statement

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14

April 5, 2023 CORRESP

3494 Martin Hurst Road * Tallahassee, Florida 32312 * (844) 878-5438

CORRESP April 5, 2023 Via Edgar Submission Division of Corporation Finance Office of Life Sciences United States Securities and Exchange Commission 100 F Street, NE Washington, D.

April 5, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): April 5, 2023 TRULIEVE CANNABIS C

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): April 5, 2023 TRULIEVE CANNABIS CORP. (Exact Name of Registrant as specified in its charter) British Columbia 000-56248 84-2231905 (State or Other Jurisdiction of Incorporation) (Comm

April 5, 2023 10-K/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 2

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 2 (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 000-562

March 8, 2023 EX-4

Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934

Exhibit 4.11 DESCRIPTION OF CAPITAL STOCK The following is a description of the capital stock of Trulieve Cannabis Corp. based on the provisions of our Articles. You should refer to our Articles, which are filed as an exhibit to our most recent Form 10‑K filed with the Securities and Exchange Commission. We encourage you to read our Articles and applicable provisions of Canadian law for additional

March 8, 2023 8-K

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 8, 2023 TRULIEVE CANNABIS CORP. (Exact Name of Registrant as specified in its charter) British Columbia 000-56248 84-2231905 (State or Other Jurisdiction of Incorporation) (Comm

March 8, 2023 EX-99.1

Trulieve Reports Fourth Quarter and Record Full Year 2022 Results Exceeding $1.2 Billion in Revenue

EX-99.1 Exhibit 99.1 Trulieve Reports Fourth Quarter and Record Full Year 2022 Results Exceeding $1.2 Billion in Revenue • Record revenue of $1.24 billion in 2022, up 32% year over year, and quarterly revenue of $302 million, with 2% retail revenue growth sequentially • Industry leading U.S. retail network of 181 dispensaries, up 14% from 2021, supported by over 4 million square feet of cultivatio

March 8, 2023 10-K

Form 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 000-56248 TRULIEVE CANNAB

March 8, 2023 EX-4

Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (incorporated by reference to Exhibit 4.11 to the Company's Annual Report on Form 10-K filed with the SEC on March 8, 2023 (File No. 000-56248))

Exhibit 4.11 DESCRIPTION OF CAPITAL STOCK The following is a description of the capital stock of Trulieve Cannabis Corp. based on the provisions of our Articles. You should refer to our Articles, which are filed as an exhibit to our most recent Form 10‑K filed with the Securities and Exchange Commission. We encourage you to read our Articles and applicable provisions of Canadian law for additional

March 8, 2023 EX-99

Appendix A (Licenses and Permits)

EXHIBIT 99.1 Appendix A Licenses and Permits State Owned or Affiliated Entity Name Licensed Address Type License # Expiration Date Regulator CA Hyperion Healing, LLC 712 Lincoln Blvd. Venice, CA 90291 Dept. of Cannabis Regulation (DCR) License 0002274403-0001-9 11/2/2022 LA Department of Cannabis Regulation CA Leef Industries, LLC 3700 E. Vista Chino, Unit D Palm Springs, CA 92262 Local Cannabis R

March 8, 2023 10-K/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 000-56248 TRULIEVE CANN

March 8, 2023 EX-99.2

Fourth Quarter and Full Year 2022 Investor Presentation / March 2023 CSE: TRUL OTCQX: TCNNF

EX-99.2 Exhibit 99.2 Fourth Quarter and Full Year 2022 Investor Presentation / March 2023 CSE: TRUL OTCQX: TCNNF Forward Looking Statements and Industry Data Unless the context otherwise requires, the terms “Trulieve,” “we,” “us” and “our” in this presentation refer to Trulieve Cannabis Corp. and its subsidiaries. Certain statements in this presentation constitute forward-looking statements within

March 8, 2023 EX-18

Preferability Letter of Marcum LLP

Exhibit 18.1 Preferability Letter The Board of Directors Trulieve Cannabis Corp. We have audited the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021 and issued our report thereon dated March 30, 2022. Note 2 to the financial statements describes a change in accounting principle for measuring deferred tax assets and liabili

March 8, 2023 EX-99

Appendix A (Licenses and Permits)

EXHIBIT 99.1 Appendix A Licenses and Permits State Entity Name Licensed Address Type License # Expiration Date Regulator MA Life Essence, Inc. 142 Southbridge ST. Worcester, MA 01068 Final Marijuana Retailer License MR282049 5/13/23 Massachusetts Cannabis Control Commission CA 805 Beach Breaks, Inc. 1053 Highland Way Grover Beach, CA 93433 Commercial Cannabis Permit C10-0000270-LIC 5/18/2023 City

March 8, 2023 EX-10

Loan Agreement dated December 21, 2022 between Trulieve Capps Highway LLC and Valley National Bank, as agent, and the lenders named therei

Exhibit 10.31 LOAN AGREEMENT by and between TRULIEVE CAPPS HIGHWAY LLC, as Borrower and VALLEY NATIONAL BANK, as Agent And THE LENDERS NAMED HEREIN, (“Lender”) Dated: as of December 21, 2022 Rev’d 12/2019 DOCPROPERTY "CUSDocIDChunk0" 9289539 v8 [Certain information indicated by [***] has been excluded from this Exhibit 10.31 because it is not material.] Rev’d 12/2019 DOCPROPERTY "CUSDocIDChunk0" 9

February 24, 2023 NT 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER: 1754195 CUSIP NUMBER: 89788C104

NT 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER: 1754195 CUSIP NUMBER: 89788C104 (Check One): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: December 31, 2022 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q For the Transition Period Ended: Read Instruction (on back page) Before Preparing Form.

February 16, 2023 SC 13G/A

TCNNF / Trulieve Cannabis Corporation / Rivers Kim A. - SC 13G/A Passive Investment

SC 13G/A 1 d434911dsc13ga.htm SC 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b),(c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. 1) 1 Trulieve Cannabis Corp. (Name of Issuer) Subordinate Voting Shares, no par value (Title of Class of Securities) 89

February 15, 2023 SC 13G/A

TCNNF / Trulieve Cannabis Corporation / Beshears Thad - SC 13G/A Passive Investment

SC 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b),(c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. 1) 1 Trulieve Cannabis Corp. (Name of Issuer) Subordinate Voting Shares, no par value (Title of Class of Securities) 89788c104 (CUSIP Number) Decembe

January 25, 2023 SC 13G/A

TCNNF / Trulieve Cannabis Corporation / Cowen Financial Products LLC - COWEN FINANCIAL PRODUCTS LLC Passive Investment

SC 13G/A 1 tcnnfa212523.htm COWEN FINANCIAL PRODUCTS LLC UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* Trulieve Cannabis Corp. (Name of Issuer) Common Stock (Title of Class of Securities) 89788c104 (CUSIP Number) December 30, 2022 (Date of Event which Requires Filing of this Statement) Check the app

January 13, 2023 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 10, 2023 TRULIEVE CANNABIS CORP. (Exact Name of Registrant as specified in its charter) British Columbia 000-56248 84-2231905 (State or Other Jurisdiction of Incorporation) (C

January 10, 2023 CORRESP

3494 Martin Hurst Road * Tallahassee, Florida 32312 * (844) 878-5438

January 10, 2023 Via Edgar Submission Division of Corporation Finance Office of Life Sciences United States Securities and Exchange Commission 100 F Street, NE Washington, D.

December 21, 2022 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 21, 2022 TRULIEVE CANNAB

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 21, 2022 TRULIEVE CANNABIS CORP. (Exact Name of Registrant as specified in its charter) British Columbia 000-56248 84-2231905 (State or Other Jurisdiction of Incorporation) (

December 21, 2022 EX-99.1

Trulieve Announces Closing of $71.5 Million Financing

EXHIBIT 99.1 Trulieve Announces Closing of $71.5 Million Financing TALLAHASSEE, Fla. ? December 21, 2022 ? Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (?Trulieve? or ?the Company?), a leading and top-performing cannabis company in the U.S., today announced the closing of a commercial loan secured by a cultivation and manufacturing site in Florida for aggregate gross proceeds of $71.5 millio

November 9, 2022 EX-99.1

Trulieve Reports Third Quarter 2022 Results and Drives Forward Progress on Strategic Vision

EX-99.1 2 d411970dex991.htm EX-99.1 Exhibit 99.1 Trulieve Reports Third Quarter 2022 Results and Drives Forward Progress on Strategic Vision • Revenue increased 34% year over year to $301 million with GAAP gross margin of 56% • Industry leading U.S. retail network of 176 dispensaries, supported by over 4 million square feet of cultivation and processing capacity • Capital, data, distribution and s

November 9, 2022 EX-99.2

Forward Looking Statements and Industry Data Unless the context otherwise requires, the terms “Trulieve,” “we,” “us” and “our” in this presentation refer to Trulieve Cannabis Corp. and its subsidiaries. Certain statements in this presentation constit

EX-99.2 Third Quarter 2022 Investor Presentation / November 2022 CSE: TRUL OTCQX: TCNNF Exhibit 99.2 Forward Looking Statements and Industry Data Unless the context otherwise requires, the terms “Trulieve,” “we,” “us” and “our” in this presentation refer to Trulieve Cannabis Corp. and its subsidiaries. Certain statements in this presentation constitute forward-looking statements within the meaning

November 9, 2022 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 9, 2022 TRULIEVE CANNABI

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 9, 2022 TRULIEVE CANNABIS CORP. (Exact Name of Registrant as specified in its charter) British Columbia 000-56248 84-2231905 (State or Other Jurisdiction of Incorporation) (C

November 9, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-56248 TRULIEVE CANNABIS CORP.

August 10, 2022 EX-99.2

Forward Looking Statements and Industry Data Unless the context otherwise requires, the terms “Trulieve,” “we,” “us” and “our” in this presentation refer to Trulieve Cannabis Corp. and its subsidiaries. Certain statements in this presentation constit

Exhibit 99.2 Second Quarter 2022 Investor Presentation / August 2022 CSE: TRUL OTCQX: TCNNF Forward Looking Statements and Industry Data Unless the context otherwise requires, the terms ?Trulieve,? ?we,? ?us? and ?our? in this presentation refer to Trulieve Cannabis Corp. and its subsidiaries. Certain statements in this presentation constitute forward?looking statements within the meaning of the U

August 10, 2022 EX-99.1

Trulieve Delivers Record Second Quarter 2022 Results Driven by Organic Retail Sales

Exhibit 99.1 Trulieve Delivers Record Second Quarter 2022 Results Driven by Organic Retail Sales ? Revenue of $320.3 million, up 49% year over year and 1% sequentially ? Retail revenue grew 3% sequentially across industry leading U.S. network of 168 dispensaries as of June 30, 2022 ? GAAP gross margin of 57% and Adjusted EBITDA* margin of 35% Tallahassee, FL ? August 10, 2022 ? Trulieve Cannabis C

August 10, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-56248 TRULIEVE CANNABIS CORP.

August 10, 2022 8-K

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 10, 2022 TRULIEVE CANNABIS CORP. (Exact Name of Registrant as specified in its charter) British Columbia 000-56248 84-2231905 (State or Other Jurisdiction of Incorporation) (Co

July 8, 2022 EX-FILING FEES

Calculation of Filing Fee Table

EX-FILING FEES 7 d353524dexfilingfees.htm EX-FILING FEES Exhibit 107 Calculation of Filing Fee Tables Form S-3 (Form Type) Trulieve Cannabis Corp. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Agg

July 8, 2022 S-3ASR

As filed with the Securities and Exchange Commission on July 7, 2022

Table of Contents As filed with the Securities and Exchange Commission on July 7, 2022 Registration No.

July 8, 2022 EX-4.19

Form of Indenture

Table of Contents Exhibit 4.19 TRULIEVE CANNABIS CORP. as Issuer and [ ] as U.S. Trustee and [ ] as Canadian Trustee Indenture Dated as of [ ] Table of Contents TABLE OF CONTENTS ARTICLE ONE DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION 1.01 Definitions 1 SECTION 1.02 Rules of Construction 9 SECTION 1.03 Compliance Certificates and Opinions 9 SECTION 1.04 Form of Documents Deli

July 8, 2022 FWP

TRULIEVE CANNABIS CORP.

FWP 1 d345133dfwp.htm FWP Issuer Free Writing Prospectus dated July 8, 2022 Filed Pursuant to Rule 433 under the Securities Act of 1933 Relating to the Preliminary Prospectus dated July 8, 2022 Registration Statement No. 333-266059 TRULIEVE CANNABIS CORP. This free writing prospectus relates to the Registration Statement on Form S-3ASR (File No. 333-266059) (the “Registration Statement”) that Trul

July 7, 2022 POS AM

As filed with the Securities and Exchange Commission on July 7, 2022

POS AM 1 d290072dposam.htm POS AM As filed with the Securities and Exchange Commission on July 7, 2022 Registration Nos. 333-252052 and 333-262299 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 4 TO FORM S-1 AND POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 TRULIEVE CANNABIS CORP. (Exact Name

July 7, 2022 POS AM

As filed with the Securities and Exchange Commission on July 7, 2022

POS AM 1 d290072dposam.htm POS AM As filed with the Securities and Exchange Commission on July 7, 2022 Registration Nos. 333-252052 and 333-262299 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 4 TO FORM S-1 AND POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 TRULIEVE CANNABIS CORP. (Exact Name

June 10, 2022 8-K

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 8, 2022 TRULIEVE CANNABIS CORP. (Exact Name of Registrant as specified in its charter) British Columbia 000-56248 84-2231905 (State or Other Jurisdiction of Incorporation) (Commi

May 24, 2022 8-K/A

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 31, 2022 TRULIEVE CANNABIS CORP. (Exact Name of Registrant as specified in its charter) British Columbia 000-56248 84-2231905 (State or Other Jurisdiction of Incorporation) (C

May 12, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-56248 TRULIEVE CANNABIS CORP.

May 12, 2022 EX-99.2

Forward Looking Statements and Industry Data Unless the context otherwise requires, the terms “Trulieve,” “we,” “us” and “our” in this presentation refer to Trulieve Cannabis Corp. and its subsidiaries. Certain statements in this presentation constit

First Quarter 2022 Investor Presentation / May 2022 CSE: TRUL OTCQX: TCNNF Exhibit 99.

May 12, 2022 EX-99.1

Trulieve Starts Year with Record First Quarter 2022 Results

Exhibit 99.1 Trulieve Starts Year with Record First Quarter 2022 Results ? Record revenue of $318.3 million, up 64% year over year and 4% sequentially ? First quarter 2022 cash flow from operations of $45.1 million and cash balance of $267 million ? Industry leading U.S. retail network of 162 dispensaries, supported by over 4.0 million square feet of cultivation and processing capacity, up 95% and

May 12, 2022 8-K

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 12, 2022 TRULIEVE CANNABIS CORP. (Exact Name of Registrant as specified in its charter) British Columbia 000-56248 84-2231905 (State or Other Jurisdiction of Incorporation) (Commi

April 28, 2022 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin

April 28, 2022 DEF 14A

Schedule 14A

DEF 14A 1 d626057ddef14a.htm DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Com

April 5, 2022 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 31, 2022 TRULIEVE CANNABIS CORP. (Exact Name of Registrant as specified in its charter) British Columbia 000-56248 84-2231905 (State or Other Jurisdiction of Incorporation) (Com

March 30, 2022 EX-18.1

Preferability Letter of Marcum LLP

Exhibit 18.1 Preferability Letter The Board of Directors Trulieve Cannabis Corp. We have audited the consolidated financial statements included in the Company?s Annual Report on Form 10-K for the year ended December 31, 2021 and issued our report thereon dated March 30, 2022. Note 2 to the financial statements describes a change in accounting principle for measuring deferred tax assets and liabili

March 30, 2022 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 000-56248 TRULIEVE CANNAB

March 30, 2022 8-K

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 30, 2022 TRULIEVE CANNABIS CORP. (Exact Name of Registrant as specified in its charter) British Columbia 000-56248 84-2231905 (State or Other Jurisdiction of Incorporation) (Com

March 30, 2022 EX-99.1

Trulieve Caps Transformational Year with Record Fourth Quarter and Full Year 2021 Results

Exhibit 99.1 Trulieve Caps Transformational Year with Record Fourth Quarter and Full Year 2021 Results ? Record revenue of $938.4 million in 2021, up 80% year over year, and quarterly revenue of $305.3 million, up 36% sequentially ? Industry leading U.S. retail network of 162 dispensaries, up 116% from 2020, supported by over 4.0 million square feet of cultivation and processing capacity, up 107%

March 30, 2022 EX-99

Appendix A (Licenses and Permits)

EXHIBIT 99.1 Appendix A Licenses and Permits State Owned or Affiliated Entity Name Licensed Address Type License # Expiration Date Regulator CA Hyperion Healing, LLC 712 Lincoln Blvd. Venice, CA 90291 Dept. of Cannabis Regulation (DCR) License 0002274403-0001-9 11/2/2022 LA Department of Cannabis Regulation CA Leef Industries, LLC 3700 E. Vista Chino, Unit D Palm Springs, CA 92262 Local Cannabis R

March 30, 2022 EX-99.2

Forward Looking Statements and Industry Data Unless the context otherwise requires, the terms “Trulieve,” “we,” “us” and “our” in this presentation refer to Trulieve Cannabis Corp. and its subsidiaries. Certain statements in this presentation constit

Fourth Quarter and Full Year 2021 Investor Presentation / March 2022 CSE: TRUL OTCQX: TCNNF Exhibit 99.

March 30, 2022 EX-4.11

Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934

EX-4.11 2 tcnnf-ex411.htm EX-4.11 Exhibit 4.11 DESCRIPTION OF CAPITAL STOCK The following is a description of the capital stock of Trulieve Cannabis Corp. based on the provisions of our Articles. You should refer to our Articles, which are filed as an exhibit to our most recent Form 10‑K filed with the Securities and Exchange Commission. We encourage you to read our Articles and applicable provisi

February 14, 2022 SC 13G

TCNNF / Trulieve Cannabis Corporation / Rivers Kim A. - SC 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Trulieve Cannabis Corp. (Name of Issuer) Subordinate Voting Shares, no par value (Title of Class of Securities) 89788c104 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the r

February 14, 2022 SC 13G

TCNNF / Trulieve Cannabis Corporation / Telogia Pharm, LLC - SC 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Trulieve Cannabis Corp. (Name of Issuer) Subordinate Voting Shares, no par value (Title of Class of Securities) 89788c104 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the r

February 14, 2022 SC 13G

TCNNF / Trulieve Cannabis Corporation / Beshears Thad - SC 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Trulieve Cannabis Corp. (Name of Issuer) Subordinate Voting Shares, no par value (Title of Class of Securities) 89788c104 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the r

February 14, 2022 EX-99.1

JOINT FILING AGREEMENT

Exhibit 99.1 JOINT FILING AGREEMENT Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree, as of February 14, 2022, that only one statement containing the information required by Schedule 13G, and each amendment thereto, need be filed with respect to the ownership by each of the undersigned of shares of Subordinate Voting Shares, no par va

February 14, 2022 EX-99.1

JOINT FILING AGREEMENT

Exhibit 99.1 JOINT FILING AGREEMENT Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree, as of February 14, 2022, that only one statement containing the information required by Schedule 13G, and each amendment thereto, need be filed with respect to the ownership by each of the undersigned of shares of Subordinate Voting Shares, no par va

February 14, 2022 SC 13G

TCNNF / Trulieve Cannabis Corporation / Shade Leaf Holding, LLC - SC 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Trulieve Cannabis Corp. (Name of Issuer) Subordinate Voting Shares, no par value (Title of Class of Securities) 89788c104 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the r

January 31, 2022 424B3

1,577,600 Subordinate Voting Shares

424B3 1 d251349d424b3.htm 424B3 Filed pursuant to Rule 424(b)(3) File No. 333-262299 PROSPECTUS 1,577,600 Subordinate Voting Shares This prospectus relates to the sale or other disposition from time to time of up to 1,577,600 subordinate voting shares, no par value, or Subordinate Voting Shares, by the selling shareholders named in this prospectus. We are not selling any Subordinate Voting Shares

January 31, 2022 EX-99.1

Trulieve Announces Closing of $75 Million Private Placement of 8% Senior Secured Notes

Exhibit 99.1 Trulieve Announces Closing of $75 Million Private Placement of 8% Senior Secured Notes TALLAHASSEE, Fla. ? Jan. 28, 2022 ? Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (?Trulieve? or ?the Company?), a leading and top-performing cannabis company in the U.S., today announced that it has closed a second tranche of its previously announced private placement of 8% Senior Secured Note

January 31, 2022 8-K

Regulation FD Disclosure, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 28, 2022 TRULIEVE CANNABIS CORP. (Exact Name of Registrant as specified in its charter) British Columbia 000-56248 84-2231905 (State or Other Jurisdiction of Incorporation) (C

January 26, 2022 CORRESP

Trulieve Cannabis Corp. 6749 Ben Bostic Road Quincy, FL 32351

Trulieve Cannabis Corp. 6749 Ben Bostic Road Quincy, FL 32351 January 26, 2022 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Trulieve Cannabis Corp. Registration Statement on Form S-1 File No. 333-262299 Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the Securities Act of 1933, as am

January 21, 2022 EX-4.10

Form of Warrant to Purchase Subordinate Voting Shares of Harvest Health & Recreation Inc., dated May 10, 2019, issued to Purchasers of 7% Unsecured Convertible Debentures (assumed by Trulieve Cannabis Corp. in connection with Harvest acquisition)

Exhibit 4.10 CERTAIN CONFIDENTIAL INFORMATION (MARKED BY BRACKETS AS ?[***]?) HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. UNLESS PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY MUST NOT TRADE THE SECURITY BEFORE [THE DATE WHICH IS FOUR MONTHS AND ONE DAY AFTER THE RELEVANT TRANCHE CLOSING

January 21, 2022 EX-4.8

Supplemental Warrant Indenture, dated as of October 1, 2021, between Trulieve Cannabis Corp., Harvest Health & Recreation, Inc. and Odyssey Trust Company (assumed by Trulieve Cannabis Corp. in connection with Harvest acquisition) (incorporated by reference to Exhibit 4.8 to the Company’s Registration Statement on Form S-1 filed with the SEC on January 21, 2022 (File No. 333-252052))

Exhibit 4.8 TRULIEVE CANNABIS CORP. - and - HARVEST HEALTH & RECREATION INC. - and - ODYSSEY TRUST COMPANY SUPPLEMENTAL WARRANT INDENTURE October 1, 2021 SUPPLEMENTAL WARRANT INDENTURE THIS SUPPLEMENTAL WARRANT INDENTURE (the ?Supplemental Warrant Indenture?) is dated as of October 1, 2021. BETWEEN: TRULIEVE CANNABIS CORP., a company incorporated under the laws of the province of British Columbia

January 21, 2022 S-1

As filed with the Securities and Exchange Commission on January 21, 2022. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FOR M S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 TRULIEVE CANNABI

Table of Contents Index to Financial Statements As filed with the Securities and Exchange Commission on January 21, 2022.

January 21, 2022 EX-4.11

Warrant dated April 23, 2020 issued by Harvest Health & Recreation, Inc. to Cumberland Property Leasing, LLC (assumed by Trulieve Cannabis Corp. in connection with Harvest acquisition) (incorporated by reference to Exhibit 4.11 to the Company’s Registration Statement on Form S-1 filed with the SEC on January 21, 2022 (File No. 333-252052))

Exhibit 4.11 UNLESS PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY MUST NOT TRADE THE SECURITY BEFORE THE DATE THAT IS 4 MONTHS AND A DAY AFTER APRIL 23, 2020. NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FR

January 21, 2022 EX-21.1

Subsidiaries of the Registrant

Exhibit 21.1 SUBSIDIARIES OF TRULIEVE CANNABIS CORP. Name Jurisdiction of Formation/Organization 1237914 B.C. LTD British Columbia Canada 181 S. Cook Industrial Parkway, LLC Georgia 21708 State Road 54, LLC Florida 450 Industry Road LLC Pennsylvania 451 Industry Road LLC Pennsylvania 805 Beach Breaks, Inc. California 850 S. Main St., LLC Connecticut 9275 W. Peoria, LLC Arizona 938 Juanita, LLC Ari

January 21, 2022 EX-10.5

Executive Employment Agreement, dated September 29, 2021, by and between Trulieve Cannabis Corp. and Kyle Landrum

Exhibit 10.5 EXECUTIVE EMPLOYMENT AGREEMENT THIS EXECUTIVE EMPLOYMENT AGREEMENT (this ?Agreement?), dated as of September 29, 2021 (the ?Effective Date?), is entered into by and between, Trulieve Cannabis Corp. (the ?Company?), and Kyle Landrum (the ?Executive?). (The Company and the Executive are sometimes individually referred to herein as a ?Party? and collectively as the ?Parties?). WHEREAS, t

January 21, 2022 EX-4.9

Replacement Purchase Warrant to Purchase Subordinate Voting Shares of Trulieve Cannabis Corp., dated October 1, 2021, issued by Trulieve Cannabis Corp. to Russon Holdings Limited (assumed by Trulieve Cannabis Corp. in connection with Harvest acquisition) (incorporated by reference to Exhibit 4.9 to the Company’s Registration Statement on Form S-1 filed with the SEC on January 21, 2022 (File No. 333-252052))

Exhibit 4.9 REPLACEMENT PURCHASE WARRANT Trulieve Cannabis Corp. Warrant Shares: 9,496 shares of Trulieve Cannabis Corp. (subject to adjustment as set forth herein) Date of Issuance: October 1, 2021 (?Replacement Issuance Date?) WHEREAS: A. On December 30, 2020 (the ?Original Issuance Date?), Harvest Health & Recreation Inc., a British Columbia, Canada corporation (?Harvest?), issued to Russon Hol

January 21, 2022 EX-4.8

Supplemental Warrant Indenture, dated October 1, 2021, by and between Trulieve Cannabis Corp., Harvest Health & Recreation Inc. and Odyssey Trust Company (assumed by Trulieve Cannabis Corp. in connection with Harvest acquisition)

Exhibit 4.8 TRULIEVE CANNABIS CORP. - and - HARVEST HEALTH & RECREATION INC. - and - ODYSSEY TRUST COMPANY SUPPLEMENTAL WARRANT INDENTURE October 1, 2021 SUPPLEMENTAL WARRANT INDENTURE THIS SUPPLEMENTAL WARRANT INDENTURE (the ?Supplemental Warrant Indenture?) is dated as of October 1, 2021. BETWEEN: TRULIEVE CANNABIS CORP., a company incorporated under the laws of the province of British Columbia

January 21, 2022 EX-10.7

Executive Employment Agreement, dated September 29, 2021, by and between Trulieve Cannabis Corp. and Tim Morey (incorporated by reference to Exhibit 10.7 to the Company’s Registration Statement on Form S-1 filed with the SEC on January 21, 2022 (File No. 333-252052))

Exhibit 10.7 EXECUTIVE EMPLOYMENT AGREEMENT THIS EXECUTIVE EMPLOYMENT AGREEMENT (this ?Agreement?), dated as of September 29, 2021 (the ?Effective Date?), is entered into by and between, Trulieve Cannabis Corp. (the ?Company?), and Tim Morey (the ?Executive?). (The Company and the Executive are sometimes individually referred to herein as a ?Party? and collectively as the ?Parties?). WHEREAS, the

January 21, 2022 POS AM

As filed with the Securities and Exchange Commission on January 21, 2022. Registration No. 333-252052 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 3 TO FORM S-1 REGISTRATION STATEMENT UNDER THE

Table of Contents As filed with the Securities and Exchange Commission on January 21, 2022.

January 21, 2022 EX-4.10

Form of Warrant to Purchase Subordinate Voting Shares of Harvest Health & Recreation Inc., dated May 10, 2019, issued to Purchasers of 7% Unsecured Convertible Debentures (assumed by Trulieve Cannabis Corp. in connection with Harvest acquisition) (incorporated by reference to Exhibit 4.10 to the Company’s Registration Statement on Form S-1 filed with the SEC on January 21, 2022 (File No. 333-252052))

Exhibit 4.10 CERTAIN CONFIDENTIAL INFORMATION (MARKED BY BRACKETS AS ?[***]?) HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. UNLESS PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY MUST NOT TRADE THE SECURITY BEFORE [THE DATE WHICH IS FOUR MONTHS AND ONE DAY AFTER THE RELEVANT TRANCHE CLOSING

January 21, 2022 EX-10.7

Executive Employment Agreement, dated September 29, 2021, by and between Trulieve Cannabis Corp. and Timothy Morey

Exhibit 10.7 EXECUTIVE EMPLOYMENT AGREEMENT THIS EXECUTIVE EMPLOYMENT AGREEMENT (this ?Agreement?), dated as of September 29, 2021 (the ?Effective Date?), is entered into by and between, Trulieve Cannabis Corp. (the ?Company?), and Tim Morey (the ?Executive?). (The Company and the Executive are sometimes individually referred to herein as a ?Party? and collectively as the ?Parties?). WHEREAS, the

January 21, 2022 EX-10.5

Executive Employment Agreement, dated September 29, 2021, by and between Trulieve Cannabis Corp. and Kyle Landrum (incorporated by reference to Exhibit 10.5 to the Company’s Registration Statement on Form S-1 filed with the SEC on January 21, 2022 (File No. 333-252052)

Exhibit 10.5 EXECUTIVE EMPLOYMENT AGREEMENT THIS EXECUTIVE EMPLOYMENT AGREEMENT (this ?Agreement?), dated as of September 29, 2021 (the ?Effective Date?), is entered into by and between, Trulieve Cannabis Corp. (the ?Company?), and Kyle Landrum (the ?Executive?). (The Company and the Executive are sometimes individually referred to herein as a ?Party? and collectively as the ?Parties?). WHEREAS, t

January 21, 2022 EX-10.28

Registration Rights Agreement dated as of July 7, 2021 by and between the Company, each of the Investors party thereto and Michael J. Badey, as the representative of each Investor

Exhibit 10.28 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this ?Agreement?) is entered into as of July 7, 2021, by and among (i) Trulieve Cannabis Corp., a Canadian corporation organized and existing under the laws of the Province of British Columbia (?Parent?), (ii) each of the equityholders of the Company set forth in Schedule 1 (individually and collectively, the ?Investor

January 21, 2022 EX-21.1

Subsidiaries of the Registrant (incorporated by reference to Exhibit 21.1 to the Company’s Registration Statement on Form S-1 filed with the SEC on January 21, 2022 (File No. 333-252052))

Exhibit 21.1 SUBSIDIARIES OF TRULIEVE CANNABIS CORP. Name Jurisdiction of Formation/Organization 1237914 B.C. LTD British Columbia Canada 181 S. Cook Industrial Parkway, LLC Georgia 21708 State Road 54, LLC Florida 450 Industry Road LLC Pennsylvania 451 Industry Road LLC Pennsylvania 805 Beach Breaks, Inc. California 850 S. Main St., LLC Connecticut 9275 W. Peoria, LLC Arizona 938 Juanita, LLC Ari

January 21, 2022 EX-10.28

Registration Rights Agreement, dated July 7, 2021, by and among Trulieve Cannabis Corp., each of the shareholders set forth therein, and Michael J. Badey, as the representative of each of the shareholders set forth therein (incorporated by reference to Exhibit 10.28 to the Company’s Registration Statement on Form S-1 filed with the SEC on January 21, 2022 (File No. 333-252052))

Exhibit 10.28 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this ?Agreement?) is entered into as of July 7, 2021, by and among (i) Trulieve Cannabis Corp., a Canadian corporation organized and existing under the laws of the Province of British Columbia (?Parent?), (ii) each of the equityholders of the Company set forth in Schedule 1 (individually and collectively, the ?Investor

January 21, 2022 EX-4.11

Warrant dated April 23, 2020 issued by Harvest Health & Recreation, Inc. (assumed by Trulieve Cannabis Corp. in connection with Harvest acquisition)

Exhibit 4.11 UNLESS PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY MUST NOT TRADE THE SECURITY BEFORE THE DATE THAT IS 4 MONTHS AND A DAY AFTER APRIL 23, 2020. NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FR

January 21, 2022 EX-4.9

Replacement Purchase Warrant dated October 1, 2021 issued by Trulieve Cannabis Corp. to Russon Holdings Limited (assumed by Trulieve Cannabis Corp. in connection with Harvest acquisition)

Exhibit 4.9 REPLACEMENT PURCHASE WARRANT Trulieve Cannabis Corp. Warrant Shares: 9,496 shares of Trulieve Cannabis Corp. (subject to adjustment as set forth herein) Date of Issuance: October 1, 2021 (?Replacement Issuance Date?) WHEREAS: A. On December 30, 2020 (the ?Original Issuance Date?), Harvest Health & Recreation Inc., a British Columbia, Canada corporation (?Harvest?), issued to Russon Hol

January 20, 2022 SC 13G/A

TCNNF / Trulieve Cannabis Corporation / Cowen Financial Products LLC - COWEN FINANCIAL PRODUCTS LLC Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Trulieve Cannabis Corp. (Name of Issuer) Common Stock (Title of Class of Securities) 89788c104 (CUSIP Number) December 31, 2021 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this

December 29, 2021 EX-10.1

Executive Employment Agreement, dated December 24, 2021, by and between Trulieve Cannabis Corp. and Steve White (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on December 29, 2021 (File No. 000-56248))

EX-10.1 2 d282002dex101.htm EX-10.1 Exhibit 10.1 EXECUTIVE EMPLOYMENT AGREEMENT THIS EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”), dated as of December 24, 2021 (the “Effective Date”), is entered into by and between, Trulieve Cannabis Corp. (the “Company”), and Steve White (the “Executive”). (The Company and the Executive are sometimes individually referred to herein as a “Party” and collecti

December 29, 2021 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 24, 2021 TRULIEVE CANNABIS CORP. (Exact Name of Registrant as specified in its charter) British Columbia 000-56248 84-2231905 (State or Other Jurisdiction of Incorporation) (

December 17, 2021 EX-99.1

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

EX-99.1 3 d276207dex991.htm EX-99.1 Exhibit 99.1 HARVEST HEALTH & RECREATION INC. INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Page Report of Independent Registered Public Accounting Firm F-2 Consolidated Balance Sheets as of December 31, 2020 and 2019 F-3 Consolidated Statements of Operations for the Years Ended December 31, 2020 and 2019 F-4 Consolidated Statements of Stockholders’ Equity for the

December 17, 2021 EX-99.3

UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION OF TRULIEVE AND HARVEST

EX-99.3 5 d276207dex993.htm EX-99.3 Exhibit 99.3 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION OF TRULIEVE AND HARVEST On October 1, 2021, Trulieve Cannabis Corp. (“Trulieve”) completed its acquisition of Harvest Health & Recreation Inc. (“Harvest”) pursuant to an Arrangement Agreement, dated May 10, 2021 (the “Arrangement”). Pursuant to the terms of the Arrangement, holders of Harv

December 17, 2021 8-K/A

Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 1, 2021 TRULIEVE CANNABIS CORP. (Exact Name of Registrant as specified in its charter) British Columbia 000-56248 84-2231905 (State or Other Jurisdiction o

December 17, 2021 EX-99.2

Table of Contents Page Financial Statements (Unaudited) 3 Condensed Consolidated Balance Sheets 3 Condensed Consolidated Statements of Operations 4 Condensed Consolidated Statements of Cash Flows 5 Condensed Consolidated Statements of Changes in Stoc

EX-99.2 4 d276207dex992.htm EX-99.2 Exhibit 99.2 HARVEST HEALTH & RECREATION INC. UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS FOR SIX MONTHS ENDED JUNE 30, 2021 HARVEST HEALTH & RECREATION INC. Table of Contents Page Financial Statements (Unaudited) 3 Condensed Consolidated Balance Sheets 3 Condensed Consolidated Statements of Operations 4 Condensed Consolidated Statements of Cash Flows 5 Condense

November 15, 2021 EX-99.2

Third Quarter 2021 Earnings Presentation November 15, 2021

Exhibit 99.2 Third Quarter 2021 Earnings Presentation November 15, 2021 Forward Looking Statements and Industry Data Unless the context otherwise requires, the terms ?Trulieve,? ?we,? ?us? and ?our? in this presentation refer to Trulieve Cannabis Corp. and its subsidiaries. Certain statements in this presentation constitute forward-looking statements within the meaning of the U.S. Private Securiti

November 15, 2021 EX-99.1

Trulieve Reports Record Third Quarter 2021 Results and 15th Consecutive Profitable Quarter Continues Execution of Hub Strategy with Harvest Acquisition U.S. Leader with 155 Retail Dispensaries 3.5 Million Square Feet of Cultivation and Processing Cap

Exhibit 99.1 Trulieve Reports Record Third Quarter 2021 Results and 15th Consecutive Profitable Quarter Continues Execution of Hub Strategy with Harvest Acquisition U.S. Leader with 155 Retail Dispensaries 3.5 Million Square Feet of Cultivation and Processing Capacity Tallahassee, FL ? November 15, 2021 ? Trulieve Cannabis Corp. (?Trulieve? or the ?Company?) (CSE: TRUL) (OTCQX: TCNNF), a leading a

November 15, 2021 8-K

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 15, 2021 TRULIEVE CANNABIS CORP. (Exact Name of Registrant as specified in its charter) British Columbia 000-56248 84-2231905 (State or Other Jurisdiction of Incorporation) (

November 15, 2021 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-56248 TRULIEVE CANNABIS CORP.

October 12, 2021 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 12, 2021 TRULIEVE CANNABIS CORP. (Exact Name of Registrant as specified in its charter) British Columbia 000-56248 84-2231905 (State or Other Jurisdiction of Incorporation) (C

October 12, 2021 EX-99.1

Forward Looking Statements and Industry and Market Data Unless the context otherwise requires, the terms “Trulieve,” “we,” “us” and “our” in this presentation refer to Trulieve Cannabis Corp. and its subsidiaries. Certain statements in this presentat

EX-99.1 2 d416750dex991.htm EX-99.1 CSE: TRUL OTCQX: TCNNF [email protected] Investor Presentation October 2021 Exhibit 99.1 Forward Looking Statements and Industry and Market Data Unless the context otherwise requires, the terms “Trulieve,” “we,” “us” and “our” in this presentation refer to Trulieve Cannabis Corp. and its subsidiaries. Certain statements in this presentation constitute forward-look

October 8, 2021 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 6, 2021 TRULIEVE CANNABIS CORP. (Exact Name of Registrant as specified in its charter) British Columbia 000-56248 84-2231905 (State or Other Jurisdiction of Incorporation) (Co

October 8, 2021 EX-99.1

Trulieve Announces Closing of $350 Million Private Placement of 8% Senior Secured Notes

EX-99.1 3 d196830dex991.htm EX-99.1 Exhibit 99.1 Trulieve Announces Closing of $350 Million Private Placement of 8% Senior Secured Notes TALLAHASSEE, Fla., – October 6, 2021 /CWN/ – Trulieve Cannabis Corp. (“Trulieve” or the “Company”) (CSE: TRUL) (OTCQX: TCNNF) today announced that it has closed its previously announced private placement of 8% Senior Secured Notes due 2026 (the “Notes”) for aggre

October 8, 2021 EX-4.1

Supplemental Trust Indenture, dated as of October 6, 2021, between Trulieve Cannabis Corp. and Odyssey Trust Company (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed with the SEC on October 8, 2021 (File No. 000-56248))

Exhibit 4.1 SUPPLEMENTAL TRUST INDENTURE THIS SUPPLEMENTAL TRUST INDENTURE dated for reference as of October 6, 2021. BETWEEN: TRULIEVE CANNABIS CORP., a corporation existing under the laws of British Columbia (the ?Issuer?) AND: ODYSSEY TRUST COMPANY, a trust company existing under the laws of Alberta and registered to carry on business in the provinces of British Columbia and Alberta (the ?Trust

October 6, 2021 EX-4.3

Harvest Health and Recreation Inc. 2018 Stock Incentive Plan (incorporated by reference to Exhibit 4.3 to the Company’s Registration Statement on Form S-8 filed with the SEC on October 6, 2021 (File No. 333-260098))

Exhibit 4.3 HARVEST HEALTH & RECREATION INC. 2018 STOCK AND INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: 2018 APPROVED BY THE COMPANY?S SHAREHOLDERS: 2018 Section 1. Purpose The purpose of the Plan is to promote the interests of the Company and its shareholders by aiding the Company in attracting and retaining employees, officers, consultants, advisors and Non-Employee Directors capable of as

October 6, 2021 S-8

As filed with the Securities and Exchange Commission on October 6, 2021

As filed with the Securities and Exchange Commission on October 6, 2021 Registration No.

October 6, 2021 EX-4.4

Harvest Health and Recreation Inc. Non-Employee Director Compensation Policy (incorporated by reference to Exhibit 4.4 to the Company’s Registration Statement on Form S-8 filed with the SEC on October 6, 2021 (File No. 333-260098))

Exhibit 4.4 HARVEST HEALTH & RECREATION INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY 1. PURPOSE This Non-Employee Director Compensation Policy (this ?Policy?) of Harvest Health & Recreation Inc., a British Columbia corporation (the ?Company?), as adopted by the Board of Directors of the Company (the ?Board?), is intended to attract highly qualified individuals to serve as non-employee directors

October 1, 2021 EX-99.1

Trulieve Completes Acquisition of Harvest Health & Recreation Inc. Creating the Largest and Most Profitable U.S. Cannabis Operator Combined Company Platform Poised for Accelerated Growth Industry Leading Footprint in Cornerstone Markets Expanded Runw

Exhibit 99.1 Trulieve Completes Acquisition of Harvest Health & Recreation Inc. Creating the Largest and Most Profitable U.S. Cannabis Operator Combined Company Platform Poised for Accelerated Growth Industry Leading Footprint in Cornerstone Markets Expanded Runway for Growth in Northeast, Southeast, and Southwest Strategic Hubs Trulieve to Host a Conference Call and Webcast Today at 8:00AM ET Tal

October 1, 2021 8-K

Regulation FD Disclosure, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 1, 2021 TRULIEVE CANNABIS CORP. (Exact name of registrant as specified in its charter) British Columbia 000-56248 84-2231905 (State or other jurisdiction of incorporation) (Co

October 1, 2021 EX-99.2

Forward Looking Statements and Industry and Market Data TRULIEVE: HARVEST ACQUISITION| October 2021 Unless the context otherwise requires, the terms “Trulieve,” “we,” “us” and “our” in this prospectus refer to Trulieve Cannabis Corp. and its subsidia

EX-99.2 3 d199176dex992.htm EX-99.2 CSE: TRUL OTCQX: TCNNF [email protected] Cultivate Together. Exhibit 99.2 Forward Looking Statements and Industry and Market Data TRULIEVE: HARVEST ACQUISITION| October 2021 Unless the context otherwise requires, the terms “Trulieve,” “we,” “us” and “our” in this prospectus refer to Trulieve Cannabis Corp. and its subsidiaries. Certain statements in this presentat

September 30, 2021 8-K

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): September 30, 2021 TRULIEVE CANNABIS CORP. (Exact Name of Registrant as specified in its charter) British Columbia 000-56248 84-2231905 (State or Other Jurisdiction of Incorporation)

September 30, 2021 EX-10.3

Executive Employment Agreement, dated September 29, 2021, by and between Trulieve Cannabis Corp. and Eric Powers (incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K filed with the SEC on September 30, 2021 (File No. 000-56248))

Exhibit 10.3 EXECUTIVE EMPLOYMENT AGREEMENT THIS EXECUTIVE EMPLOYMENT AGREEMENT (this ?Agreement?), dated as of September 29, 2021 (the ?Effective Date?), is entered into by and between, Trulieve Cannabis Corp. (the ?Company?), and Eric Powers (the ?Executive?). (The Company and the Executive are sometimes individually referred to herein as a ?Party? and collectively as the ?Parties?). WHEREAS, th

September 30, 2021 EX-99.1

Trulieve Announces $350 Million Private Placement of 8% Senior Secured Notes Leverages Industry Leading Balance Sheet to Provide for Retirement of Certain Harvest Health & Recreation Debt Upon Completion of Acquisition

EX-99.1 2 d112435dex991.htm EX-99.1 Exhibit 99.1 Trulieve Announces $350 Million Private Placement of 8% Senior Secured Notes Leverages Industry Leading Balance Sheet to Provide for Retirement of Certain Harvest Health & Recreation Debt Upon Completion of Acquisition TALLAHASSEE, Fla., – September 30, 2021 /CWN/ – Trulieve Cannabis Corp. (“Trulieve” or the “Company”) (CSE: TRUL) (OTCQX: TCNNF) tod

September 30, 2021 EX-10.1

Executive Employment Agreement, dated September 29, 2021, by and between Trulieve Cannabis Corp. and Kimberly Rivers (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on September 30, 2021 (File No. 000-56248))

Exhibit 10.1 EXECUTIVE EMPLOYMENT AGREEMENT THIS EXECUTIVE EMPLOYMENT AGREEMENT (this ?Agreement?), dated as of September 29, 2021 (the ?Effective Date?), is entered into by and between, Trulieve Cannabis Corp. (the ?Company?), and Kimberly Rivers (the ?Executive?). (The Company and the Executive are sometimes individually referred to herein as a ?Party? and collectively as the ?Parties?). WHEREAS

September 30, 2021 EX-10.2

Executive Employment Agreement, dated September 29, 2021, by and between Trulieve Cannabis Corp. and Alex D’Amico (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed with the SEC on September 30, 2021 (File No. 000-56248))

EX-10.2 3 d144211dex102.htm EX-10.2 Exhibit 10.2 EXECUTIVE EMPLOYMENT AGREEMENT THIS EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”), dated as of September 29, 2021 (the “Effective Date”), is entered into by and between, Trulieve Cannabis Corp. (the “Company”), and Alex D’Amico (the “Executive”). (The Company and the Executive are sometimes individually referred to herein as a “Party” and collec

September 30, 2021 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): September 28, 2021 TRULIEVE CANNABIS CORP. (Exact Name of Registrant as specified in its charter) British Columbia 000-56248 84-2231905 (State or Other Jurisdiction of Incorporation)

September 30, 2021 EX-10.4

Executive Employment Agreement, dated September 29, 2021, by and between Trulieve Cannabis Corp. and Rebecca Young (incorporated by reference to Exhibit 10.4 to the Company’s Current Report on Form 8-K filed with the SEC on September 30, 2021 (File No. 000-56248))

Exhibit 10.4 EXECUTIVE EMPLOYMENT AGREEMENT THIS EXECUTIVE EMPLOYMENT AGREEMENT (this ?Agreement?), dated as of September 29, 2021 (the ?Effective Date?), is entered into by and between, Trulieve Cannabis Corp. (the ?Company?), and Rebecca Young (the ?Executive?). (The Company and the Executive are sometimes individually referred to herein as a ?Party? and collectively as the ?Parties?). WHEREAS,

September 17, 2021 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): September 15, 2021 TRULIEVE CANNABIS CORP. (Exact Name of Registrant as specified in its charter) British Columbia 000-56248 84-2231905 (State or Other Jurisdiction of Incorporation)

September 17, 2021 EX-10.2

Restricted Share Unit Award Agreement dated as of September 15, 2021 by and between Trulieve Cannabis Corp. and Jason B. Pernell Family Trust, as the assignee of Jason Pernell (replaced the Amended and Restated Warrant to Purchase Subordinate Voting Shares of Trulieve Cannabis Corp., dated as of September 21, 2018, by and between Trulieve, Inc. and the Jason B. Pernell Family Trust dated July 31, 2020 (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed with the SEC on September 17, 2021 (File No. 000-56248))

Exhibit 10.2 RESTRICTED SHARE UNIT AWARD AGREEMENT THIS AGREEMENT (?Agreement?) is made and entered into as of September 15, 2021 (the ?Effective Date?), by and between Trulieve Cannabis Corp. (?Trulieve?) and Jason B. Pernell Family Trust, as the assignee of Jason Pernell, who also serves as trustee (collectively the ?Employee? or ?you?). Trulieve and Employee are individually referred to as a ?P

September 17, 2021 EX-10.1

Restricted Share Unit Award Agreement dated as of September 15, 2021 by and between Trulieve Cannabis Corp. and Kim Rivers (replaced the Warrant to Purchase Subordinate Voting Shares of Trulieve Cannabis Corp., dated September 21, 2018, by and between Trulieve, Inc. and Kim Rivers) (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on September 17, 2021 (File No. 000-56248))

Exhibit 10.1 RESTRICTED SHARE UNIT AWARD AGREEMENT THIS AGREEMENT (?Agreement?) is made and entered into as of September 15, 2021 (the ?Effective Date?), by and between Trulieve Cannabis Corp. (?Trulieve?) and Kim Rivers (the ?Employee? or ?you?). Trulieve and Employee are individually referred to as a ?Party? and collectively referred to as the ?Parties.? WHEREAS, the Company previously issued th

September 15, 2021 POS AM

As filed with the Securities and Exchange Commission on September 14, 2021. Registration No. 333-252052 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 2 TO FORM S-1 REGISTRATION STATEMENT UNDER TH

Table of Contents As filed with the Securities and Exchange Commission on September 14, 2021.

September 15, 2021 EX-24.2

Power of Attorney (Giannella Alvarez)

Exhibit 24.2 POWER OF ATTORNEY KNOW ALL BY THESE PRESENTS that the individual whose signature appears below constitutes and appoints each of Kim Rivers and Eric Powers as such person’s true and lawful attorney-in-fact and agent with full power of substitution and resubstitution, for such person in such person’s name, place and stead, in any and all capacities, to sign any and all amendments (inclu

September 15, 2021 EX-10.28

Registration Rights Agreement dated as of July 7, 2021 by and between the Company, each of the Investors party thereto and Michael J. Badey, as the representative of each Investor

Exhibit 10.28 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this ?Agreement?) is entered into as of July 7, 2021, by and among (i) Trulieve Cannabis Corp., a Canadian corporation organized and existing under the laws of the Province of British Columbia (?Parent?), (ii) each of the equityholders of the Company set forth in Schedule 1 (individually and collectively, the ?Investor

September 15, 2021 EX-24.3

Power of Attorney (Jane Morreau)

Exhibit 24.3 POWER OF ATTORNEY KNOW ALL BY THESE PRESENTS that the individual whose signature appears below constitutes and appoints each of Kim Rivers and Eric Powers as such person’s true and lawful attorney-in-fact and agent with full power of substitution and resubstitution, for such person in such person’s name, place and stead, in any and all capacities, to sign any and all amendments (inclu

August 30, 2021 S-8

As filed with the Securities and Exchange Commission on August 30, 2021

Form S-8 As filed with the Securities and Exchange Commission on August 30, 2021 Registration No.

August 26, 2021 SC 13G

TCNNF / Trulieve Cannabis Corporation / Cowen Financial Products LLC - COWEN FINANCIAL PRODUCTS LLC Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Trulieve Cannabis Corp. (Name of Issuer) Common Stock (Title of Class of Securities) 89788c104 (CUSIP Number) August 13, 2021 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [

August 24, 2021 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 24, 2021 TRULIEVE CANNABIS

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 24, 2021 TRULIEVE CANNABIS CORP. (Exact Name of Registrant as specified in its charter) British Columbia 000-56248 84-2231905 (State or Other Jurisdiction of Incorporation) (Co

August 24, 2021 EX-99.1

Forward Looking Statements and Industry and Market Data Unless the context otherwise requires, the terms “Trulieve,” “we,” “us” and “our” in this prospectus refer to Trulieve Cannabis Corp. and its subsidiaries. Certain statements in this presentatio

Exhibit 99.1 Live without Investor Presentation limits. August 2021Exhibit 99.1 Live without Investor Presentation limits. August 2021 Forward Looking Statements and Industry and Market Data Unless the context otherwise requires, the terms ?Trulieve,? ?we,? ?us? and ?our? in this prospectus refer to Trulieve Cannabis Corp. and its subsidiaries. Certain statements in this presentation constitute fo

August 12, 2021 EX-10.1

Second Amendment to Promissory Note, dated May 3, 2021, by and between George Hackney, Inc. d/b/a Trulieve and Kim Rivers (incorporated by reference to Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q filed with the SEC on August 12, 2021 (File No. 000-56248)).

Exhibit 10.1 SECOND AMENDMENT TO PROMISSORY NOTE THIS SECOND AMENDMENT TO PROMISSORY NOTE (the ?Amendment?) is dated as of March 2, 2021 by and between Trulieve, Inc., formerly known as George Hackney, Inc. (?Borrower?) and Kim Rivers (?Lender?). WHEREAS, Lender and Borrower are parties to that certain Promissory Note May 24, 2018 (the ?Promissory Note?); and WHEREAS, Lender and Borrower wish to a

August 12, 2021 EX-10.2

Second Amendment to Promissory Note, dated May 3, 2021, by and between George Hackney, Inc. d/b/a Trulieve and Traunch Four, LLC (incorporated by reference to Exhibit 10.2 to the Company’s Quarterly Report on Form 10-Q filed with the SEC on August 12, 2021 (File No. 000-56248)).

Exhibit 10.2 SECOND AMENDMENT TO PROMISSORY NOTE THIS SECONDAMENDMENT TO PROMISSORY NOTE (the ?Amendment?) is dated as of March 2, 2021 by and between Trulieve, Inc., formerly known as George Hackney, Inc. (?Borrower?) and Traunch Four, LLC (?Lender?). WHEREAS, Lender and Borrower are parties to that certain Promissory Note May 24, 2018 (the ?Promissory Note?); and WHEREAS, Lender and Borrower wis

August 12, 2021 EX-99.1

Trulieve Reports Record Second Quarter 2021 Earnings and Expansion into New Markets Achieved a number of firsts and records including 14th consecutive quarter of profitability and over 500,000 customers served; Became the first medical cannabis opera

Exhibit 99.1 Trulieve Reports Record Second Quarter 2021 Earnings and Expansion into New Markets Achieved a number of firsts and records including 14th consecutive quarter of profitability and over 500,000 customers served; Became the first medical cannabis operator to start planting in West Virginia; and Positioned to enter our 7th state with Production License Approval in Georgia Tallahassee, FL

August 12, 2021 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-56248 TRULIEVE CANNABIS CORP.

August 12, 2021 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 12, 2021 TRULIEVE CANNABIS CORP. (Exact Name of Registrant as specified in its charter) British Columbia 000-56248 84-2231905 (State or Other Jurisdiction of Incorporation) (Co

July 7, 2021 8-K

Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): July 2, 2021 TRULIEVE CANNABIS CORP. (Exact Name of Registrant as specified in its charter) British Columbia 000-56248 84-2231905 (State or Other Jurisdiction of Incorporation) (Commi

July 7, 2021 EX-16.1

July 5, 2021

EX-16.1 2 d183815dex161.htm EX-16.1 Exhibit 16.1 July 5, 2021 Securities and Exchange Commission Washington, D.C. 20549 Commissioners: We have read Trulieve Cannabis Corp.’s statements included under Item 4.01 (a) of its Form 8-K filed on July 7, 2021 and we agree with such statements concerning our Firm. Very truly yours, /s/ MNP LLP

June 11, 2021 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 10, 2021 TRULIEVE CANNABIS CORP. (Exact Name of Registrant as specified in its charter) British Columbia 000-56248 84-2231905 (State or Other Jurisdiction of Incorporation) (Comm

June 11, 2021 EX-10.1

Trulieve Cannabis Corp. 2021 Omnibus Incentive Plan (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on June 11, 2021 (File No. 000-56248))

EX-10.1 2 d153937dex101.htm EX-10.1 Exhibit 10.1 Trulieve Cannabis Corp. 2021 Omnibus Incentive Plan Contents Article 1. Establishment, Purpose 1 Article 2. Definitions 1 Article 3. Administration 6 Article 4. Shares Subject to The Plan, Maximum Awards and Minimum Vesting Standards 7 Article 5. Eligibility and Participation 9 Article 6. Stock Options 9 Article 7. Stock Appreciation Rights 11 Artic

June 4, 2021 EX-99.1

Forward Looking Statements and Industry and Market Data Unless the context otherwise requires, the terms “Trulieve,” “we,” “us” and “our” in this prospectus refer to Trulieve Cannabis Corp. and its subsidiaries. Certain statements in this presentatio

Exhibit 99.1 Relief you can rely on Investor Presentation | June 2021Exhibit 99.1 Relief you can rely on Investor Presentation | June 2021 Forward Looking Statements and Industry and Market Data Unless the context otherwise requires, the terms ?Trulieve,? ?we,? ?us? and ?our? in this prospectus refer to Trulieve Cannabis Corp. and its subsidiaries. Certain statements in this presentation constitut

June 4, 2021 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 4, 2021 TRULIEVE CANNABIS CORP. (Exact Name of Registrant as specified in its charter) British Columbia 000-56248 84-2231905 (State or Other Jurisdiction of Incorporation) (Commi

May 13, 2021 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-56248 TRULIEVE CANNABIS CORP.

May 13, 2021 EX-10.2

Form of Voting Support Agreement (incorporated by reference to Exhibit 10.2 to the Company’s Quarterly Report on Form 10-Q filed with the SEC on May 13, 2021 (File No. 000-56248))

Exhibit 10.2 VOTING SUPPORT AGREEMENT THIS VOTING SUPPORT AGREEMENT (?Agreement?) is dated as of , 2021, by and between Trulieve Cannabis Corp., a corporation existing under the laws of the Province of British Columbia, (?Trulieve?) and each of the shareholders listed on Exhibit A attached hereto (individually, a ?Shareholder? and collectively, the ?Shareholders?). WHEREAS, the Shareholder is the

May 13, 2021 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 13, 2021 TRULIEVE CANNABIS CORP. (Exact Name of Registrant as specified in its charter) British Columbia 000-56248 84-2231905 (State or Other Jurisdiction of Incorporation) (Commi

Other Listings
DE:T0A 6,10 €
CA:TRUL
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista